2010
DOI: 10.1016/j.jchromb.2009.11.032
|View full text |Cite
|
Sign up to set email alerts
|

Determination of nicotine and cotinine in human serum by means of LC/MS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
35
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(41 citation statements)
references
References 24 publications
6
35
0
Order By: Relevance
“…Several analytical methods for the quantification of nicotine and/or its metabolites in different biological samples were described, including plasma [8][9][10][11], serum [12][13][14], urine [15][16][17][18], breast milk [19,20] and oral fluid/saliva [12,21]. The majority of methods used liquid chromatography (LC) systems coupled with single quadrupole mass spectrometric (MS) detection [10,14] or triple quadrupole mass spectrometry (MS/MS) [8,9,15,16,19]. Sample preparation was mostly performed by solid phase extraction (SPE) [8][9][10]12,15,16] or by liquid-liquid extraction (LLE) [13,19].…”
Section: Introductionmentioning
confidence: 99%
“…Several analytical methods for the quantification of nicotine and/or its metabolites in different biological samples were described, including plasma [8][9][10][11], serum [12][13][14], urine [15][16][17][18], breast milk [19,20] and oral fluid/saliva [12,21]. The majority of methods used liquid chromatography (LC) systems coupled with single quadrupole mass spectrometric (MS) detection [10,14] or triple quadrupole mass spectrometry (MS/MS) [8,9,15,16,19]. Sample preparation was mostly performed by solid phase extraction (SPE) [8][9][10]12,15,16] or by liquid-liquid extraction (LLE) [13,19].…”
Section: Introductionmentioning
confidence: 99%
“…515 Furthermore tumor clonogen repopulation 516 and tumor hypoxia 517 may further confound the calculation of accurate alpha-to-beta ratios. 520 Prospective randomized trials evaluating hypofractionation for early stage prostate cancer are summarized in Table 53-6. Although older, pre-PSA-era series did not show a time factor, an analysis of clinical outcomes from several analyses suggest that a longer overall treatment time was associated with a worse biochemical failure for patients with low-risk prostate cancer.…”
Section: Disease Sitesmentioning
confidence: 99%
“…Pretreatment processing is also needed for LC/MS analysis. The pretreatment methods include ultrafiltration, extraction, solid phase extraction [36,37], and column switch [38].…”
Section: Characteristics Of Gas Chromatography-mass Spectrometrymentioning
confidence: 99%